Results 181 to 190 of about 36,256,275 (202)
Tuberous Sclerosis Complex Diagnostic Criteria Update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference [PDF]
Pediatric Neurology, 2013 BackgroundTuberous sclerosis complex is highly variable in clinical presentation and findings. Disease manifestations continue to develop over the lifetime of an affected individual.
Harry Chugani +2 more
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
2010
Retinoblastoma tumour suppressor Rb is a cell cycle regulator that is active during early G1 preventing the transition from G1 to S-phase. This is achieved by Rb inhibiting E2F transcription factors from activating expression of genes required for G1 to S-phase progression and DNA synthesis. In our initial genetic test searching for genes that interact
openaire +1 more source
Retinoblastoma tumour suppressor Rb is a cell cycle regulator that is active during early G1 preventing the transition from G1 to S-phase. This is achieved by Rb inhibiting E2F transcription factors from activating expression of genes required for G1 to S-phase progression and DNA synthesis. In our initial genetic test searching for genes that interact
openaire +1 more source
Architecture of the Tuberous Sclerosis Protein Complex
Journal of Molecular Biology, 2021Kailash Ramlaul +2 more
exaly
Epilepsy and Neurodevelopmental Comorbidities in Tuberous Sclerosis Complex: A Natural History Study
Pediatric Neurology, 2020Mustafa Şahin +2 more
exaly
Tuberous sclerosis complex: Recent advances in manifestations and therapy
International Journal of Urology, 2017Motohide Uemura +2 more
exaly
Topical Rapamycin Therapy to Alleviate the Cutaneous Manifestations of Tuberous Sclerosis Complex
Drugs in R and D, 2012Mary Kay Koenig +2 more
exaly